These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 23768737
1. Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer. Lee CH, Hyun MK, Jang EJ, Lee NR, Kim K, Yim JJ. Respir Med; 2013 Aug; 107(8):1222-33. PubMed ID: 23768737 [Abstract] [Full Text] [Related]
2. Use of inhaled corticosteroids and the risk of tuberculosis. Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ. Thorax; 2013 Dec; 68(12):1105-13. PubMed ID: 23749841 [Abstract] [Full Text] [Related]
3. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA, Fabbri LM, Davis KJ, Soriano JB. Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [Abstract] [Full Text] [Related]
4. Inhaled corticosteroids in COPD and the risk of lung cancer. Lee YM, Kim SJ, Lee JH, Ha E. Int J Cancer; 2018 Nov 01; 143(9):2311-2318. PubMed ID: 29943812 [Abstract] [Full Text] [Related]
5. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP. Curr Med Res Opin; 2012 Dec 01; 28(12):1959-67. PubMed ID: 23098081 [Abstract] [Full Text] [Related]
6. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L. Ann Pharmacother; 2010 Apr 01; 44(4):613-22. PubMed ID: 20233915 [Abstract] [Full Text] [Related]
7. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD. Wu MF, Jian ZH, Huang JY, Jan CF, Nfor ON, Jhang KM, Ku WY, Ho CC, Lung CC, Pan HH, Wu MC, Liaw YP. BMC Cancer; 2016 Oct 10; 16(1):778. PubMed ID: 27724847 [Abstract] [Full Text] [Related]
8. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Lee TA, Weiss KB. Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795 [Abstract] [Full Text] [Related]
10. Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma. Jian ZH, Huang JY, Lin FC, Nfor ON, Jhang KM, Ku WY, Ho CC, Lung CC, Pan HH, Wu MC, Wu MF, Liaw YP. PLoS One; 2016 Apr 01; 11(7):e0159683. PubMed ID: 27448321 [Abstract] [Full Text] [Related]
11. The association of asthma and atrial fibrillation--a nationwide population-based nested case-control study. Chan WL, Yang KP, Chao TF, Huang CC, Huang PH, Chen YC, Chen TJ, Lin SJ, Chen JW, Leu HB. Int J Cardiol; 2014 Sep 20; 176(2):464-9. PubMed ID: 25127961 [Abstract] [Full Text] [Related]
12. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder. Chen S, Plauschinat CA, Wu N, Fraser K, Boulanger L. J Med Econ; 2011 Sep 20; 14(4):458-62. PubMed ID: 21651427 [Abstract] [Full Text] [Related]
13. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM, Culler SD, Ershoff D, Gutierrez B. Clin Ther; 2009 Nov 20; 31(11):2574-83. PubMed ID: 20110003 [Abstract] [Full Text] [Related]
14. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. O'Byrne PM, Rennard S, Gerstein H, Radner F, Peterson S, Lindberg B, Carlsson LG, Sin DD. Respir Med; 2012 Nov 20; 106(11):1487-93. PubMed ID: 22902134 [Abstract] [Full Text] [Related]
15. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study. Eurich DT, Lee C, Marrie TJ, Majumdar SR. Clin Infect Dis; 2013 Oct 20; 57(8):1138-44. PubMed ID: 23872948 [Abstract] [Full Text] [Related]
16. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM. Curr Med Res Opin; 2009 Sep 20; 25(9):2251-8. PubMed ID: 19622006 [Abstract] [Full Text] [Related]
17. Corticosteroids and the risk of atrial fibrillation. van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH. Arch Intern Med; 2006 May 08; 166(9):1016-20. PubMed ID: 16682576 [Abstract] [Full Text] [Related]
18. Adherence to inhaled corticosteroid use and local adverse events in persistent asthma. Ivanova JI, Birnbaum HG, Hsieh M, Yu AP, Seal B, van der Molen T, Emani S, Rosiello RA, Colice GL. Am J Manag Care; 2008 Dec 08; 14(12):801-9. PubMed ID: 19067497 [Abstract] [Full Text] [Related]
19. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Marcus P, Oppenheimer EA, Patel PA, Katz LM, Doyle JJ. Ann Allergy Asthma Immunol; 2006 May 08; 96(5):736-43. PubMed ID: 16729789 [Abstract] [Full Text] [Related]
20. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Hojo M, Iikura M, Hirano S, Sugiyama H, Kobayashi N, Kudo K. Respirology; 2012 Jan 08; 17(1):185-90. PubMed ID: 21995339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]